Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil

Block of the hERG potassium channel and prolongation of the QT interval are predictors of drug‐induced torsade de pointes. However, drugs that block the hERG potassium channel may also block other channels that mitigate torsade risk. We hypothesized that the electrocardiogram can differentiate the e...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics Vol. 96; no. 5; pp. 549 - 558
Main Authors: Johannesen, L, Vicente, J, Mason, J W, Sanabria, C, Waite-Labott, K, Hong, M, Guo, P, Lin, J, Sørensen, J S, Galeotti, L, Florian, J, Ugander, M, Stockbridge, N, Strauss, D G
Format: Journal Article
Language:English
Published: United States Blackwell Publishing Ltd 01-11-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Block of the hERG potassium channel and prolongation of the QT interval are predictors of drug‐induced torsade de pointes. However, drugs that block the hERG potassium channel may also block other channels that mitigate torsade risk. We hypothesized that the electrocardiogram can differentiate the effects of multichannel drug block by separate analysis of early repolarization (global J–Tpeak) and late repolarization (global Tpeak–Tend). In this prospective randomized controlled clinical trial, 22 subjects received a pure hERG potassium channel blocker (dofetilide) and three drugs that block hERG and either calcium or late sodium currents (quinidine, ranolazine, and verapamil). The results show that hERG potassium channel block equally prolongs early and late repolarization, whereas additional inward current block (calcium or late sodium) preferentially shortens early repolarization. Characterization of multichannel drug effects on human cardiac repolarization is possible and may improve the utility of the electrocardiogram in the assessment of drug‐related cardiac electrophysiology. Clinical Pharmacology & Therapeutics (2014); 96 5, 549–558. doi:10.1038/clpt.2014.155
Bibliography:Supplementary Figure S1
ArticleID:CPTCLPT2014155
istex:55A8391D9E89C10DF5B05DB164F9CF56785F64BD
ark:/67375/WNG-QGBMLX0W-B
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0009-9236
1532-6535
1532-6535
DOI:10.1038/clpt.2014.155